ANAVEX LIFE SCIENCES CORP. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Anavex Life Sciences Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Anavex Life Sciences Corp. Operating Income (Loss) for the quarter ending June 30, 2024 was -$14.7M, a 8.85% decline year-over-year.
  • Anavex Life Sciences Corp. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$51.2M, a 12.3% increase year-over-year.
  • Anavex Life Sciences Corp. annual Operating Income (Loss) for 2023 was -$55.8M, a 9.36% decline from 2022.
  • Anavex Life Sciences Corp. annual Operating Income (Loss) for 2022 was -$51M, a 21.4% decline from 2021.
  • Anavex Life Sciences Corp. annual Operating Income (Loss) for 2021 was -$42M, a 35.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$55.8M -$4.77M -9.36% Oct 1, 2022 Sep 30, 2023 10-K 2023-11-27
2022 -$51M -$8.98M -21.4% Oct 1, 2021 Sep 30, 2022 10-K 2023-11-27
2021 -$42M -$10.9M -35.1% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-27
2020 -$31.1M Oct 1, 2019 Sep 30, 2020 10-K 2022-11-28
2014 -$2.97M -$832K -38.9% Oct 1, 2013 Sep 30, 2014 10-K 2014-12-29
2013 -$2.14M +$2.18M +50.5% Oct 1, 2012 Sep 30, 2013 10-K 2014-12-29
2012 -$4.32M +$1.86M +30.1% Oct 1, 2011 Sep 30, 2012 10-K 2013-12-30
2011 -$6.18M -$532K -9.42% Oct 1, 2010 Sep 30, 2011 10-K 2012-12-31
2010 -$5.65M Oct 1, 2009 Sep 30, 2010 10-K 2011-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.